SCS
ARRY

Syquant Capital SAS’s Array Biopharma Inc ARRY Stock Holding History

Syquant Capital SAS’s Portfolio ARRY Stock Details ARRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-417,100
Closed -$19.3M – 26
2019
Q2 		$19.3M Buy
+417,100
New +$11.7M 6.2% 5

Other funds holding ARRY

ASN
Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

Syquant Capital SAS's ARRY Position: Q3 2019 in Review

Syquant Capital SAS sold out of Array Biopharma Inc (ARRY) in Q3 2019, closing a stake of 417,100 shares — an estimated $19.3M sold.

Syquant Capital SAS first reported a position in ARRY in Q2 2019 and held it in 1 quarter. The position peaked at $19.3M in Q2 2019. 1 fund tracked by Wall St. Rank holds ARRY as of Q3 2019.

  • Syquant Capital SAS reported no remaining Array Biopharma Inc position as of Q3 2019 after selling out during the quarter.
  • Syquant Capital SAS sold 417,100 Array Biopharma Inc shares in Q3 2019, an estimated $19.3M.
  • Syquant Capital SAS first reported a position in Array Biopharma Inc in Q2 2019 and held it in 1 quarter.
  • Syquant Capital SAS's Array Biopharma Inc position peaked at $19.3M in Q2 2019.
  • 1 fund tracked by Wall St. Rank held Array Biopharma Inc as of Q3 2019.

Based on Syquant Capital SAS's 13F filing for Q3 2019, filed 17 Oct 2019.